MedImmune LLC

MedImmune Way ,
Gaithersburg, Maryland 20878
United States,
(301) 398-0000
www.medimmune.com

MedImmune strives to provide better medicines to patients, new medical options for physicians, rewarding careers to employees, and increased value to shareholders. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. With approximately 2,000 employees worldwide, MedImmune is headquartered in Maryland.

M&A Summary

Buy vs Sell

Year ≤ '12 '13 '14 '15 '16 '17 T
Buy (1.0/yr) # 2 5 - - - - 7
vol $492M $965M $1.5B
Sell (0.0/yr) # - - - - - - 0
  7

Top M&A Advisors

Financial Deals
Join to Access.
Legal Deals
Join to Access.

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Amplimmune, Inc.
$500M (2013-08-26)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View

MedImmune was acquired by AstraZeneca on June 01, 2007.

MedImmune has acquired 7 companies of its own, including 5 in the last 5 years. A total of 2 acquisitions came from private equity firms.

MedImmune’s largest acquisition to date was in 2013, when it acquired Amplimmune for $500M. MedImmune has acquired in 3 different US states, and 3 countries. The Company’s most targeted sectors include life science (86%).

When analyzing the medical products sector as a whole, according to Mergr, in the last 3 years, there are 332 medical products companies that have made at least 1 acquisition, 16 have acquired at least 5 companies, and 4 have acquired more than 10 companies. The most prolific strategic medical products acquirer over the past 3 years is Boston Scientific, with 12 acquisitions. The most prolific private equity acquirer in the medical products sector over the past 3 years is SHS GmbH with 4 platform acquisitions.

Join Mergr and gain access to MedImmune’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.3K Private Equity Firms
  • 113K M&A Transactions
  • 123K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 37K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.